The Swiss Federal Council has approved the new SwissDRG system for 2018

Dec 2017

The further-developed tariff structure SwissDRG was approved by the Federal Council in Switzerland. The new tariff version for inpatient services will be effective from January 1st in 2018. The tariff structure SwissDRG defines how inpatient services in the acute care area of the hospitals and birthplaces are reimbursed within the framework of compulsory health care insurance in Switzerland.

Compared to the last version, the number of case groups in the new DRG catalog remains stable overall. The number of add-on payments (Zusatzentgelte, ZE) on the other hand has increased. These payments are used to for the additional reimbursement of especially costly services.

The following new add-on payments that are related to medical devices were included in the SwissDRG catalog for 2018:

ZE-2018-104.01 - Hemodialysis to remove proteins with a molecular mass up to 60,000, extended intermittently - 1,792.10 CHF
ZE-2018-109.01- ZE-2018-109.05 - Endoscopic insertion of bronchial valve(s), amount depending on number of valves - 2,128.40 to 10,642.00 CHF
ZE-2018-105 - Autogenic matrix-induced chondrocyte transplantation at the knee joint - 5,614.00 CHF
ZE-2018-107.01 - Proton therapy - 1,412.75 CHF
ZE-2018-108.01 - Externally delivered anesthesia service - 774.95 CHF

The SwissDRG catalog for 2018 in PDF and Excel versions is available here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

2022 RIHN and Supplementary list for IVD tests published in France

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

New procedure and diagnostic codes added to the private reimbursement schedule in England

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Theme survey on products for monitoring and diagnostics of sepsis launched by Swedish TLV

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Healthcare Implementation Communique updated in Turkey

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Two more health apps obtained reimbursement in Germany

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.